{
  "instance_id": 347,
  "chat_eval": "1",
  "answer": "KCNJ11",
  "extracted_solution_or_last_step": "# Identification of Likely Causal Gene for Type 2 Diabetes\n\n## Analysis Summary\n\nBased on a comprehensive analysis of literature, disease databases, and functional evidence, **KCNJ11** is identified as the most likely causal gene for Type 2 diabetes within the given locus.\n\n## Key Findings\n\n### 1. Disease Database Evidence (OMIM)\n- **KCNJ11**: Directly associated with \"Diabetes mellitus, type 2, susceptibility to\" (MIM: 125853)\n- **ABCC8**: Associated with diabetes mellitus, noninsulin-dependent (MIM: 125853) [same phenotype]\n- **KCNJ11** also shows associations with:\n  - Permanent neonatal diabetes mellitus\n  - Maturity-onset diabetes of the young (MODY)\n  - Transient neonatal diabetes mellitus\n\n### 2. Literature Evidence\n**KCNJ11** demonstrated the strongest literature support:\n- Multiple studies specifically examining KCNJ11 variants (rs5219) in Type 2 diabetes populations\n- Research documenting KCNJ11 polymorphism associations with:\n  - Type 2 diabetes risk [1]\n  - Cardiovascular and renal diabetes complications [2]\n  - Insulin signaling and cellular bioenergetics [3]\n\n### 3. Molecular Function\n**KCNJ11** encodes the ATP-sensitive inward rectifier potassium channel 11 (Kir6.2), which serves as:\n- The **pore-forming subunit** of ATP-sensitive potassium (KATP) channels in pancreatic beta cells\n- The primary functional component controlling glucose-stimulated insulin secretion\n- A direct mechanistic link to diabetes pathophysiology through insulin release regulation\n\n**ABCC8** encodes the sulfonylurea receptor 1 (SUR1), which functions as:\n- A regulator subunit that interacts with KCNJ11\n- Required for channel activation and regulation\n- More prominent in neonatal diabetes than Type 2 diabetes\n\n### 4. Clinical Relevance\n- **KCNJ11** variants directly impact Type 2 diabetes susceptibility\n- **KCNJ11** is the primary target for diabetes drug development\n- **KCNJ11** polymorphisms (rs5219) are established diabetes risk factors\n\n## Conclusion\n\n**KCNJ11** shows the strongest evidence for being the causal gene for Type 2 diabetes in this locus based on:\n1. Direct OMIM database association with Type 2 diabetes susceptibility\n2. Robust literature support for KCNJ11 variants in diabetes risk\n3. Primary functional role in insulin secretion regulation\n4. Strong mechanistic connection to diabetes pathophysiology\n5. Clinical relevance as a drug target for diabetes treatment\n\nWhile ABCC8 contributes to channel function, KCNJ11 serves as the principal functional component with the most direct evidence linking it to Type 2 diabetes causality.\n\n---\n\n**References:**\n[1] KCNJ11 rs5219 polymorphism studies in diabetes populations  \n[2] Literature on KCNJ11 variants and diabetes complications  \n[3] Research on KCNJ11's role in insulin signaling pathways",
  "error": null,
  "last_200_tokens": "insulin secretion - A direct mechanistic link to diabetes pathophysiology through insulin release regulation **ABCC8** encodes the sulfonylurea receptor 1 (SUR1), which functions as: - A regulator subunit that interacts with KCNJ11 - Required for channel activation and regulation - More prominent in neonatal diabetes than Type 2 diabetes ### 4. Clinical Relevance - **KCNJ11** variants directly impact Type 2 diabetes susceptibility - **KCNJ11** is the primary target for diabetes drug development - **KCNJ11** polymorphisms (rs5219) are established diabetes risk factors ## Conclusion **KCNJ11** shows the strongest evidence for being the causal gene for Type 2 diabetes in this locus based on: 1. Direct OMIM database association with Type 2 diabetes susceptibility 2. Robust literature support for KCNJ11 variants in diabetes risk 3. Primary functional role in insulin secretion regulation 4. Strong mechanistic connection to diabetes pathophysiology 5. Clinical relevance as a drug target for diabetes treatment While ABCC8 contributes to channel function, KCNJ11 serves as the principal functional component with the most direct evidence linking it to Type 2 diabetes causality. --- **References:** [1] KCNJ11 rs5219 polymorphism studies in diabetes populations [2] Literature on KCNJ11 variants and diabetes complications [3] Research on KCNJ11's role in insulin signaling pathways </solution>",
  "answer_count_in_last_200_tokens": 10,
  "potential_answer_with_has_is": "KCNJ11",
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": "KCNJ11",
  "potential_answer_emerges": null,
  "count_potential_answer_with_has_is": 17,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 17,
  "count_potential_answer_emerges": 0,
  "prompt": "Your task is to identify likely causal genes within a locus for a given GWAS phenotype. From the list, provide only the likely causal gene (matching one of the given genes). \nIdentify the causal gene.\nGWAS phenotype: Type 2 diabetes (type II diabetes mellitus)\nGenes in locus: {ABCC8},{KCNC1},{KCNJ11},{MYOD1},{NCR3LG1},{NUCB2},{OTOG},{PIK3C2A},{PLEKHA7},{RPS13},{SERGEF},{USH1C}\n",
  "task_name": "gwas_causal_gene_opentargets",
  "execution_time": 1875.0046951770782
}